Icahn Reports New Stakes In Genzyme, Forest Labs At Sept 30
NEW YORK -(Dow Jones)- Billionaire investor Carl Icahn reported new stakes in Genzyme Corp. (GENZ) and Forest Laboratories Inc. (FRX), while selling his investment in Endo Pharmaceuticals Holdings Inc. (ENDP), as of Sept. 30, according to regulatory filings.
2009-11-17 -
Nasdaq